Mizuho Securities Co. Ltd. Merck & Co., Inc. Transaction History

Mizuho Securities Co. Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $3,258 - $3,551	30 New	30 $3,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $15,826 - $20,291	181 Added 90.95%	380 $42,000
Q3 2022 Oct 27, 2022	SELL	$84.53 - $94.96 $189,431 - $212,805	-2,241 Reduced 91.84%	199 $15,000
Q2 2022 Jul 21, 2022	SELL	$83.49 - $94.64 $130,327 - $147,733	-1,561 Reduced 39.02%	2,440 $187,000
Q1 2022 Apr 15, 2022	BUY	$73.51 - $82.4 $247,140 - $277,028	3,362 Added 526.13%	4,001 $328,000
Q4 2021 Feb 04, 2022	SELL	$72.28 - $90.54 $712,753 - $892,814	-9,861 Reduced 93.91%	639 $49,000
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $745,328 - $819,674	10,398 Added 10194.12%	10,500 $789,000
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $70 - $77	1 Added 0.99%	102 $8,000
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $2,547 - $3,001	-37 Reduced 26.81%	101 $8,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $9,904 - $10,991	138 New	138 $11,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.